PFE, has entered a global licensing agreement with Novavax to use Matrix-M adjuvant technology in the development of up to ...
Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...
Maryland-based Novavax signed a licensing agreement allowing Pfizer access to its technology that boosts immune responses to ...
By Michael Erman and Christy Santhosh Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results